Premium
This is an archive article published on April 7, 2011

Cadila shares up 3 pct on USFDA nod

Cadila Healthcare rose more than 3 per cent after the company said it got US FDA approval to conduct phase-I trials for a diabetes drug.

Shares of Cadila Healthcare rose more than 3 per cent after the company said it got US FDA approval to conduct phase-I trials for a diabetes drug.

At 11.12 a.m.,shares of the company were up 2.63 per cent at Rs 824.

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
Advertisement